Evidence map›Paper›PMID 36611104›Full record

ArticleInternational urology and nephrology2023

Bibliometric analysis of ferroptosis in acute kidney injury from 2014 to 2022.

Chao Liu, Wuhong Zhou, Zhi Mao, Xiaoming Li, Qing Meng, Rui Fan, Yibo Zhou, Li Zhang, Quan Hong, Xuefeng Sun and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in International urology and nephrology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 2 pooled it
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 2 syntheses or guidelines pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. CircRNA and ferroptosis in human disease: Insights for new treatments.Animal models and experimental medicine · 2023
    Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 3 countries.

Chao Liu *Department of Critical Care Medicine, The First Medical Center of Chinese People's Liberation Army General Hospital, 28 Fu-Xing Road, Beijing, 100853, People's Republic of China.
Wuhong Zhou *Outpatient Department, 984th Hospital of Joint Logistic Support Force of Chinese People's Liberation Army, Beijing, China.
Zhi MaoDepartment of Critical Care Medicine, The First Medical Center of Chinese People's Liberation Army General Hospital, 28 Fu-Xing Road, Beijing, 100853, People's Republic of China.
Xiaoming LiDepartment of Critical Care Medicine, The First Medical Center of Chinese People's Liberation Army General Hospital, 28 Fu-Xing Road, Beijing, 100853, People's Republic of China.
Qing MengIAE de Paris-Sorbonne Business School, University Paris 1 Pantheon Sorbonne, 75020, Paris, France.
Rui FanJohns Hopkins Bloomberg School of Public Health, Baltimore, MD, 21205, US.
Yibo ZhouDepartment of Critical Care Medicine, The First Medical Center of Chinese People's Liberation Army General Hospital, 28 Fu-Xing Road, Beijing, 100853, People's Republic of China.
Li ZhangDepartment of Operating Room, People's Hospital of Xinjiang Uygur Autonomous Region, Xin Jiang, 830001, China.
Quan HongDepartment of Nephrology, The First Medical Center of Chinese, State Key Laboratory of Kidney Diseases, PLA General Hospital, Chinese PLA Institute of Nephrology, National Clinical Research Center for Kidney Diseases, 28 Fuxing Road, Beijing, China.
Xuefeng SunDepartment of Nephrology, The First Medical Center of Chinese, State Key Laboratory of Kidney Diseases, PLA General Hospital, Chinese PLA Institute of Nephrology, National Clinical Research Center for Kidney Diseases, 28 Fuxing Road, Beijing, China.
Feihu ZhouDepartment of Critical Care Medicine, The First Medical Center of Chinese People's Liberation Army General Hospital, 28 Fu-Xing Road, Beijing, 100853, People's Republic of China. feihuzhou301@126.com.ORCID http://orcid.org/0000-0001-6154-013X
People's Liberation Army No. 150 Hospital · CNChinese PLA General Hospital · CNChinese People's Liberation Army · CNJohns Hopkins University · USPeople's Hospital of Xinjiang Uygur Autonomous Region · CNUniversité Paris 1 Panthéon-Sorbonne · FR

Funding

National Natural Science Foundation of China 81871581National Natural Science Foundation of China 82200780
6 · The paper itself

Abstract

introductionAcute kidney injury (AKI) is a global disease with high morbidity and mortality. At present, the treatment of AKI still lacks targeted measures. Ferroptosis, a form of regulated cell death, plays an essential role in the initiation and progression of AKI. Current evidence proves that targeting ferroptosis is supposed to be a novel potential strategy to cure AKI. In this study, we aim to use bibliometric analysis to identify research trends and hotspots in the field of "ferroptosis in AKI".

methodsWe chose the Science Citation Index Expanded (SCI-EXPANDED) index of the Web of Science Core Collection (WoSCC) as the source database for data retrieval. Data were retrieved from the WoSCC on May 24, 2022. Full records and cited references of all the documents in WoSCC were collected. The R software and the Online Analysis Platform of Literature Metrology were used for data analysis and visual analysis.

resultsThere were 120 documents on "ferroptosis in AKI" in the WOSCC from 2014 to 2022 (May 24, 2022). There was a clear upward trend each year in the number of documents published. According to WoS report, China, the United States, and Germany were the top three countries involved in this research area, the majority of publications were included in the subject area "Cell Biology". Technical University of Dresden contributed the most publications, followed by Central South University and University of Pittsburgh. The Journal of Cell Death and Disease had the highest H-index and contributed the most publications. Linkermann A authored 16 articles and had the highest H-index. Multifactorial analysis of the keywords show that the research field is divided into two clusters. The most contributing publications and the most cited publications were also determined by factorial analysis.

conclusionThis bibliometric analysis provides a comprehensive analysis of research trends and hot spots on the topic of "ferroptosis in AKI". The study of ferroptosis-related AKI research remains in its early stages. There will be a dramatically increasing number of publications on this field. Further research should focus on exploring the mechanisms of crosstalk between ferroptosis and other programmed cell deaths, and improves clinical applications and therapeutic effects against AKI.

Indexed as

Acute Kidney InjuryFerroptosisRegulated Cell DeathApoptosisBibliometricsHumansAcute kidney injuryBibliometric analysisFerroptosisWeb of Science

Identifiers

PMID36611104
OpenAlexW4313704713

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.